Established in 2017, Hims & Hers Health (NYSE: HIMS) is a relatively young company addressing age-old healthcare challenges by offering prescription medications, over-the-counter products ...

In this article, we are going to take a look at where Hims & Hers Health, Inc. (NYSE: HIMS) stands against other best beauty stocks to buy according to hedge funds. According to a report by ...

Hims & Hers Health (NYSE: HIMS) is coming off a fantastic year in 2024 when its share price skyrocketed 172%. The telehealth company has been growing at a fast rate, making it one of the best ...

We recently published a list of 12 Best Beauty Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Hims & Hers Health, Inc. (NYSE: HIMS) stands against other ...

Hims & Hers has also moved from a loss-making company to one that is highly profitable. Its net income rose to $75.6 million, while the adjusted EBITDA soared by 317% to $51.1 million. Earnings ahead ...

Hims & Hers’ Super Bowl ad plugs its compounded weight loss drugs as the “affordable” solution to a “sick system,” but many concerns about safety still swirl around these forms of the ...

Hims has a great deal of meme potential, which could benefit the company by effectively acting as free advertising. Putting aside Hims meme potential, the company is still in a great position to ...

Telehealth company Hims & Hers is running its first Super Bowl ad and it appears to be poised to become one of the most talked about ads in recent memory. The 60 second spot is provocative and ...